Ebola Virus Disease
📧 Sign up to get email alerts when something new happens for Ebola Virus Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2020-05-29New vaccine for prevention of Ebola virus disease recommended for approval in the European Union
The European Medicines Agency recommends approval of a new Ebola virus disease vaccine for use in the European Union to prevent Ebola virus …
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004) [Phase 1]
Phase 1 trial update for VSV-EBOV vaccine (V920) in healthy adults, reporting dose response and safety/immunogenicity results.
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) [Phase 1]
Phase 1 clinical trial update for an Ebola vaccine (V920-001) completed with results posted.
-
EMA approval · 2019-10-18First vaccine to protect against Ebola
The EMA announced the first vaccine that protects against Ebola, marking a major advance in prevention of Ebola virus disease.
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002) [Phase 1]
Phase 1 trial reporting safety and immunogenicity of prime-boost VSV Ebola vaccine (V920-002) in healthy adults; results completed and poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea [Phase 2, Phase 3]
A phase 2/3 trial evaluated convalescent plasma for Ebola Virus Disease in Guinea; status completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection [Phase 1, Phase 2]
Clinical trials evaluating putative investigational therapeutics for Ebola Virus Infection are completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination [Phase 1]
This update reports a Phase 1 evaluation of a new Ebola vaccine using a short-interval prime-boost, with the trial status marked as complete…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine [Phase 3]
A Phase 3 trial update provides additional information on the safety and effectiveness of an Ebola vaccine.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo [Phase 1]
Phase 1 trial update on two Ebola vaccines, ChAd3-EBO Z and MVA-BN Filo; the Oxford study has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, and immunogenicity of the Ebola vaccine cAd3-EBO in healthy adults.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study [Phase 1]
Phase 1 safety study of Poly-ICLC aimed at preventing respiratory viral infections has completed, evaluating its safety in conditions includ…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children [Phase 2]
Phase 2 trial evaluating the safety and immunogenicity of GlaxoSmithKline’s Ebola vaccine ChAd3-EBO-Z in children, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV [Phase 1]
Phase 1 trial results for two Ebola vaccine candidates, ChAd3-EBO-Z and Ad26.ZEBOV, have been completed.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) [Phase 2, Phase 3]
STRIVE in Sierra Leone completed Phase 2/3 evaluation of two Ebola vaccines (rVSV-ZEBOV and ChAd3-EBO-Z) with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults [Phase 2]
Phase 2 trial assessing safety and immunogenicity of a candidate Ebola vaccine in adults; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda [Phase 1]
This is a Phase 1 clinical trial update assessing Ebola vaccine candidates cAd3-EBO, cAd3-EBOZ, and MVA-EbolaZ in healthy adults in Uganda; …
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) [Phase 2]
Phase 2 trial update from PREVAIL on Ebola vaccines conducted in Liberia; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Ebola and Marburg Virus Vaccines [Phase 1]
A Phase 1 trial evaluating Ebola and Marburg virus vaccines has completed. The study was sponsored by the National Institute of Allergy and …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Experimental Vaccine for Prevention of Ebola Virus Infection [Phase 1]
Phase 1 clinical trial of an experimental Ebola virus vaccine conducted by NIAID has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants [Phase 1]
This Phase 1 trial evaluated safety and immunogenicity of heterologous and homologous prime-boost Ebola vaccine regimens in healthy particip…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP) [Phase 1]
Phase I trial evaluating the safety, tolerability, and immunogenicity of the Ebola vaccine rVSVΔG-ZEBOV-GP.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults [Phase 1]
Phase 1 clinical trial update assessing safety and immunogenicity of an Ebola Zaire vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults [Phase 1]
A Phase 1 trial in healthy adults evaluated the safety and immune response of the HPIV3-EbovZ GP Ebola vaccine, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants [Phase 1]
This Phase 1 trial evaluated the safety and immunogenicity of heterologous prime-boost Ebola vaccine regimens in healthy participants. The s…